1. Home
  2. SPT vs CMPX Comparison

SPT vs CMPX Comparison

Compare SPT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$8.44

Market Cap

485.7M

Sector

Technology

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.91

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPT
CMPX
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.7M
408.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
SPT
CMPX
Price
$8.44
$1.91
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$11.75
$14.57
AVG Volume (30 Days)
925.9K
2.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
32.11
N/A
EPS
N/A
N/A
Revenue
$457,547,000.00
N/A
Revenue This Year
$8.86
N/A
Revenue Next Year
$8.04
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
12.72
N/A
52 Week Low
$4.92
$1.61
52 Week High
$16.03
$6.88

Technical Indicators

Market Signals
Indicator
SPT
CMPX
Relative Strength Index (RSI) 55.28 34.71
Support Level $7.47 $1.88
Resistance Level $9.12 $2.02
Average True Range (ATR) 0.48 0.10
MACD -0.01 -0.02
Stochastic Oscillator 60.10 10.20

Price Performance

Historical Comparison
SPT
CMPX

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: